Treatment timeline and outcomes of patients with relapsed pPCL
| Treatment . | Median time from diagnosis (range), mo . | Median lines of therapy (range) . | mPFS (95% CI), mo . | mOS (95% CI), mo . |
|---|---|---|---|---|
| Cilta-cel | 24 (8-92) | 4 (4-6) | 19 (3 to NE) | NE (5 to NE) |
| Ide-cel | 36 (26-54) | 6 (4-7) | 6 (2 to NE) | NE (8 to NE) |
| Treatment . | Median time from diagnosis (range), mo . | Median lines of therapy (range) . | mPFS (95% CI), mo . | mOS (95% CI), mo . |
|---|---|---|---|---|
| Cilta-cel | 24 (8-92) | 4 (4-6) | 19 (3 to NE) | NE (5 to NE) |
| Ide-cel | 36 (26-54) | 6 (4-7) | 6 (2 to NE) | NE (8 to NE) |